Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells

Background: The study aimed to examine the impact of stem cell treatment on quality of life (QoL) and sexual functioning in women with androgenetic alopecia (AGA). Methods: Twenty-three women underwent a single session of autologous cellular micrografts (ACMs). The World Health Organization Quality...

Full description

Bibliographic Details
Main Authors: Katarzyna Krefft-Trzciniecka, Hanna Cisoń, Alicja Pakiet, Danuta Nowicka, Jacek C. Szepietowski
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/12/6/608
_version_ 1797240811906138112
author Katarzyna Krefft-Trzciniecka
Hanna Cisoń
Alicja Pakiet
Danuta Nowicka
Jacek C. Szepietowski
author_facet Katarzyna Krefft-Trzciniecka
Hanna Cisoń
Alicja Pakiet
Danuta Nowicka
Jacek C. Szepietowski
author_sort Katarzyna Krefft-Trzciniecka
collection DOAJ
description Background: The study aimed to examine the impact of stem cell treatment on quality of life (QoL) and sexual functioning in women with androgenetic alopecia (AGA). Methods: Twenty-three women underwent a single session of autologous cellular micrografts (ACMs). The World Health Organization Quality of Life Brief Version (WHOQOL-BREF) and Female Sexual Function Index (FSFI) were used before and after 6 months. Results: The AGA severity decreased by an average of 1 point on the Ludwig scale (<i>p</i> = 0.004) after treatment. FSFI scores indicated sexual dysfunction in over half of the women at baseline, but they improved significantly post-treatment for arousal [median (IQR): 4.8 (1.5) vs. 5.10 (0.9); <i>p</i> = 0.035] and satisfaction [4.4 (1.4) vs. 4.8 (1.8); <i>p</i> = 0.025]. QoL scores improved after treatment in psychological health (57.96 ± 19.0 vs. 69.35 ± 14.0; <i>p</i> = 0.031) and environment (72.96 ± 13.4 vs. 81.09 ± 12.6; <i>p</i> = 0.007), but not in physical health and social relationships. No associations were found between the WHOQOL-BREF or FSFI domains versus age and AGA severity. Conclusions: AGA reduces QoL and impacts sexual functioning in women with AGA. The high treatment burden arises from the chronic and progressive nature of AGA, coupled with limited treatment effectiveness. Effective treatments for AGA, like ACM, are urgently needed to enhance patient-reported outcomes along with clinical results.
first_indexed 2024-04-24T18:13:22Z
format Article
id doaj.art-46a24d7a2be7426e84acc807f33dc163
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-04-24T18:13:22Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-46a24d7a2be7426e84acc807f33dc1632024-03-27T13:43:34ZengMDPI AGHealthcare2227-90322024-03-0112660810.3390/healthcare12060608Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem CellsKatarzyna Krefft-Trzciniecka0Hanna Cisoń1Alicja Pakiet2Danuta Nowicka3Jacek C. Szepietowski4Department of Dermatology, Venereology and Allergology, Wrocław Medical University, 50-368 Wrocław, PolandDepartment of Dermatology, Venereology and Allergology, Wrocław Medical University, 50-368 Wrocław, PolandDepartment of Dermatology, Venereology and Allergology, Wrocław Medical University, 50-368 Wrocław, PolandDepartment of Dermatology, Venereology and Allergology, Wrocław Medical University, 50-368 Wrocław, PolandDepartment of Dermatology, Venereology and Allergology, Wrocław Medical University, 50-368 Wrocław, PolandBackground: The study aimed to examine the impact of stem cell treatment on quality of life (QoL) and sexual functioning in women with androgenetic alopecia (AGA). Methods: Twenty-three women underwent a single session of autologous cellular micrografts (ACMs). The World Health Organization Quality of Life Brief Version (WHOQOL-BREF) and Female Sexual Function Index (FSFI) were used before and after 6 months. Results: The AGA severity decreased by an average of 1 point on the Ludwig scale (<i>p</i> = 0.004) after treatment. FSFI scores indicated sexual dysfunction in over half of the women at baseline, but they improved significantly post-treatment for arousal [median (IQR): 4.8 (1.5) vs. 5.10 (0.9); <i>p</i> = 0.035] and satisfaction [4.4 (1.4) vs. 4.8 (1.8); <i>p</i> = 0.025]. QoL scores improved after treatment in psychological health (57.96 ± 19.0 vs. 69.35 ± 14.0; <i>p</i> = 0.031) and environment (72.96 ± 13.4 vs. 81.09 ± 12.6; <i>p</i> = 0.007), but not in physical health and social relationships. No associations were found between the WHOQOL-BREF or FSFI domains versus age and AGA severity. Conclusions: AGA reduces QoL and impacts sexual functioning in women with AGA. The high treatment burden arises from the chronic and progressive nature of AGA, coupled with limited treatment effectiveness. Effective treatments for AGA, like ACM, are urgently needed to enhance patient-reported outcomes along with clinical results.https://www.mdpi.com/2227-9032/12/6/608stem cell therapyregenerative therapyandrogenetic alopeciaquality of lifefemale sexual function
spellingShingle Katarzyna Krefft-Trzciniecka
Hanna Cisoń
Alicja Pakiet
Danuta Nowicka
Jacek C. Szepietowski
Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
Healthcare
stem cell therapy
regenerative therapy
androgenetic alopecia
quality of life
female sexual function
title Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
title_full Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
title_fullStr Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
title_full_unstemmed Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
title_short Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
title_sort enhancing quality of life and sexual functioning in female androgenetic alopecia therapeutic potential of hair follicle derived stem cells
topic stem cell therapy
regenerative therapy
androgenetic alopecia
quality of life
female sexual function
url https://www.mdpi.com/2227-9032/12/6/608
work_keys_str_mv AT katarzynakreffttrzciniecka enhancingqualityoflifeandsexualfunctioninginfemaleandrogeneticalopeciatherapeuticpotentialofhairfolliclederivedstemcells
AT hannacison enhancingqualityoflifeandsexualfunctioninginfemaleandrogeneticalopeciatherapeuticpotentialofhairfolliclederivedstemcells
AT alicjapakiet enhancingqualityoflifeandsexualfunctioninginfemaleandrogeneticalopeciatherapeuticpotentialofhairfolliclederivedstemcells
AT danutanowicka enhancingqualityoflifeandsexualfunctioninginfemaleandrogeneticalopeciatherapeuticpotentialofhairfolliclederivedstemcells
AT jacekcszepietowski enhancingqualityoflifeandsexualfunctioninginfemaleandrogeneticalopeciatherapeuticpotentialofhairfolliclederivedstemcells